Latest Commercialization News

Elanor Commercial Property Fund’s Independent Board Committee unanimously recommends rejecting Lederer’s unsolicited $0.70 per security takeover bid, supported by an Independent Expert’s report deeming the offer neither fair nor reasonable.

INOVIQ Limited has obtained exclusive worldwide rights to novel ovarian cancer biomarker IP from UniQuest, propelling its EXO-OC™ test closer to commercial launch. The test’s exceptional sensitivity and specificity position it as a potential breakthrough in early cancer detection.

Murray Cod Australia Limited reports a profitable FY25 with a significant biomass increase and completes a $17 million capital raise to fund infrastructure and market expansion ahead of a commercial inflection in FY26.

Tamboran Resources has reported record natural gas flow rates from its Shenandoah South 2H sidetrack well and initiated the largest drilling program ever seen in the Beetaloo Basin, alongside securing key approvals for gas sales.

Aspen Group has entered a conditional contract to acquire the remaining stages of the Wallaroo Shores master planned community in South Australia for $14.1 million, significantly boosting its development pipeline in a fast-growing region.

Xstate Resources has commenced drilling operations at its Diona-1 well in Queensland, targeting promising gas reservoirs with a rapid path to market.

MC Mining Limited has appointed Yi (Christine) He as its permanent Managing Director and CEO, cementing leadership ahead of key coal production milestones at the Makhado Project.

Memphasys Limited is intensifying its commercial push for Felix, an innovative automated sperm separation system for IVF, backed by a landmark Middle East partnership and a fresh capital raise to scale manufacturing and sales.

1414 Degrees has returned to trading after issuing 35.7 million shares to US investor Lind Global Fund II, with approval for an additional 14.3 million shares pending at the upcoming AGM.

Whitebark Energy has installed hydrogen sensors at the Rickerscote prospect to refine drilling plans for a major exploration well in late 2026, aiming to unlock vast hydrogen, helium, and hydrocarbon resources.

Recce Pharmaceuticals has initiated patient dosing in its pivotal Phase 3 trial for diabetic foot infections in Indonesia, targeting a significant market with high diabetes prevalence. Interim results expected in early 2026 could accelerate regulatory approval and commercial launch.

Environmental Clean Technologies Limited (ECT) is set to acquire exclusive rights to Rice University’s innovative Flash Joule Heating technology, promising a breakthrough in PFAS soil remediation. The company also announces a $3 million capital raise to accelerate development and commercialisation.